Food and Drug Administration

Correction: Genetic Frontiers-Blindness-Gene Therapy story

In a story Oct. 9 about an experimental gene therapy for blindness, The Associated Press erroneously reported the deadline for a decision by the U.S. Food and Drug Administration. The date is Jan. 12, not Jan. 18.

A corrected version of the story is below:

Seeing hope: FDA panel considers gene therapy for blindness

Advisers to the U.S. Food and Drug Administration will meet Thursday to consider whether to recommend approval of a gene therapy aimed at restoring vision for some people with hereditary blindness

By MARILYNN MARCHIONE

AP Chief Medical Writer

A girl saw her mother's face for the first time. A boy tore through the aisles of Target,...

52°